The current standard of care for patients with T1DM consists of exogenous insulin administration to normalize glycemia; specifically, intensive insulin therapy (IIT) which involves the maintenance of blood glucose within the 4-9 mmol/l range (2). Here, INS is linked to type 1 diabetes mellitus.